Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed
Bioventus Employees
Bioventus had 960 employees as of September 26, 2026. The number of employees increased by 10 or 1.05% compared to the same quarter last year. That makes Bioventus the 15,235th largest employer in the world and 2,189th in the United States.
Employees
960
Change (1Y)
10
Growth (1Y)
1.05%
Revenue / Employee
$610,041
Profits / Employee
$59,683
Market Cap
832.50M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 26, 2026 | 960 | 10 | 1.05% |
| Jun 27, 2026 | 950 | 0 | - |
| Mar 28, 2026 | 940 | 10 | 1.08% |
| Dec 31, 2025 | 930 | 0 | - |
| Sep 27, 2025 | 950 | -80 | -7.77% |
| Jun 28, 2025 | 950 | -80 | -7.77% |
| Mar 29, 2025 | 930 | -65 | -6.53% |
| Dec 31, 2024 | 930 | -40 | -4.12% |
| Sep 28, 2024 | 1,030 | 60 | 6.19% |
| Jun 29, 2024 | 1,030 | 80 | 8.42% |
| Mar 30, 2024 | 995 | -45 | -4.33% |
| Dec 31, 2023 | 970 | -150 | -13.39% |
| Sep 30, 2023 | 970 | -190 | -16.38% |
| Jul 1, 2023 | 950 | -210 | -18.10% |
| Apr 1, 2023 | 1,040 | -110 | -9.57% |
| Dec 31, 2022 | 1,120 | -80 | -6.67% |
| Oct 1, 2022 | 1,160 | 260 | 28.89% |
| Jul 2, 2022 | 1,160 | 260 | 28.89% |
| Apr 2, 2022 | 1,150 | 250 | 27.78% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 2, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 3, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 3, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 26, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 27, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Integra LifeSciences Holdings | 4,427 |
| Varex Imaging | 2,500 |
| Artivion | 1,800 |
| Cytek Biosciences | 703 |
| InMode | 660 |
| OrthoPediatrics | 602 |
| Beta Bionics | 423 |
BVS News
- 10 days ago - 3 Small-Cap Healthcare Stocks with More Than 45% Upside, According to Analysts - TipRanks
- 17 days ago - Bioventus price target lowered to $16 from $18 at Craig-Hallum - TheFly
- 17 days ago - Bioventus price target lowered to $16 from $18 at Barrington - TheFly
- 17 days ago - Bioventus price target lowered to $18 from $19 at Canaccord - TheFly
- 18 days ago - Bioventus Earnings Call Transcript: Q3 2026 - Transcripts
- 18 days ago - Bioventus Earnings release: Q3 2026 - Filings
- 18 days ago - Bioventus Quarterly report: Q3 2026 - Filings
- 18 days ago - Bioventus Slides: Q3 2026 - Filings